Similar articles for PMID: 22130823

Year	Number of Results
2002	1
2003	3
2004	2
2005	5
2006	6
2007	15
2008	7
2009	8
2010	20
2011	14
2012	11
2013	10
2014	6
2015	2
2021	1
2022	1
2023	1
2024	0

1

The management of Eisenmenger syndrome in the modern treatment era: a case report.

Gatzoulis MA. Gatzoulis MA. Eur Respir Rev. 2011 Dec;20(122):293-6. doi: 10.1183/09059180.00006211. Eur Respir Rev. 2011. PMID: 22130823 Free PMC article. No abstract available.

2

Pulmonary arterial hypertension: combination therapy in the modern management era.

Sitbon O. Sitbon O. Eur Respir Rev. 2010 Dec;19(118):348-9. doi: 10.1183/09059180.00008310. Eur Respir Rev. 2010. PMID: 21119195 Free PMC article. No abstract available.

3

[Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].

Raposo-Sonnenfeld I, Otero-González I, Blanco-Aparicio M, Ferrer-Barba A, Medrano-López C. Raposo-Sonnenfeld I, et al. Rev Esp Cardiol. 2007 Apr;60(4):366-72. Rev Esp Cardiol. 2007. PMID: 17521545 Free article. Spanish.

4

[Bosentan and chronic thromboembolic pulmonary hypertension].

Tomás C, Callejas-Rubio JL, Ríos-Fernández R, Ortego-Centeno N. Tomás C, et al. Med Clin (Barc). 2007 Nov 3;129(16):639. doi: 10.1157/13111817. Med Clin (Barc). 2007. PMID: 18001681 Spanish. No abstract available.

5

"Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation.

Hoeper MM. Hoeper MM. Eur Respir Rev. 2011 Dec;20(122):297-300. doi: 10.1183/09059180.00005511. Eur Respir Rev. 2011. PMID: 22130824 Free PMC article. No abstract available.

6

Bosentan for the treatment of portopulmonary hypertension.

Tempe DK, Datt V, Datta D. Tempe DK, et al. Ann Card Anaesth. 2008 Jul-Dec;11(2):139-40; author reply 140. doi: 10.4103/0971-9784.41595. Ann Card Anaesth. 2008. PMID: 18603763 No abstract available.

7

Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.

D'Alto M, Romeo E, Argiento P, Sarubbi B, Santoro G, Grimaldi N, Correra A, Scognamiglio G, Russo MG, Calabrò R. D'Alto M, et al. Int J Cardiol. 2012 Mar 22;155(3):378-82. doi: 10.1016/j.ijcard.2010.10.051. Epub 2010 Nov 16. Int J Cardiol. 2012. PMID: 21081251 Clinical Trial.

8

The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.

Zeng WJ, Lu XL, Xiong CM, Shan GL, Liu ZH, Ni XH, Gu Q, Zhao ZH, Li JJ, He JG; Sildenafil Therapy on Pulmonary Arterial Hypertension Associated With Different Types of Congenital Heart Disease Study Group. Zeng WJ, et al. Clin Cardiol. 2011 Aug;34(8):513-8. doi: 10.1002/clc.20917. Epub 2011 Jun 15. Clin Cardiol. 2011. PMID: 21678455 Free PMC article. Clinical Trial.

9

Treatment of severe pulmonary hypertension secondary to scleroderma: a three-drug approach.

Catapano-Minotti G, Corsonello A, Guadalupi G, Spani R, Antonelli-Incalzi R. Catapano-Minotti G, et al. Intern Med. 2008;47(6):511-3. doi: 10.2169/internalmedicine.47.0565. Epub 2008 Mar 17. Intern Med. 2008. PMID: 18344637 Free article.

10

Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?

Brancaccio G, Toscano A, Bevilacqua M, Di Chiara L, Parisi F. Brancaccio G, et al. Pediatr Transplant. 2007 Feb;11(1):110-2. doi: 10.1111/j.1399-3046.2006.00606.x. Pediatr Transplant. 2007. PMID: 17239133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year